Cargando…

Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas

BACKGROUND: Despite increased understanding of the genetic events underlying pediatric high-grade gliomas (pHGGs), therapeutic progress is static, with poor understanding of nongenomic drivers. We therefore investigated the role of alterations in mitochondrial function and developed an effective com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Han, Yu, Man, Tsoli, Maria, Chang, Cecilia, Joshi, Swapna, Liu, Jie, Ryall, Scott, Chornenkyy, Yevgen, Siddaway, Robert, Hawkins, Cynthia, Ziegler, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Pediatric Neuro-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954438/ https://www.ncbi.nlm.nih.gov/pubmed/31398252 http://dx.doi.org/10.1093/neuonc/noz140

Ejemplares similares

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes
por: Green, Katherine, et al.
Publicado: (2022)

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
por: Stundon, Jennifer L, et al.
Publicado: (2022)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study
por: Acharya, Sahaja, et al.
Publicado: (2019)

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908
por: Dunkel, Ira J, et al.
Publicado: (2023)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Mapping pediatric brain tumors to their origins in the developing cerebellum
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus
por: Foss-Skiftesvik, Jon, et al.
Publicado: (2023)

Challenges for the functional diffusion map in pediatric brain tumors
por: Grech-Sollars, Matthew, et al.
Publicado: (2014)

Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas
por: Schramm, Peter, et al.
Publicado: (2010)

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
por: Cantor, Evan, et al.
Publicado: (2022)

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening
por: Kojic, Marija, et al.
Publicado: (2023)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021)

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis
por: Thust, S. C., et al.
Publicado: (2018)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
por: Doz, François, et al.
Publicado: (2021)

Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas
por: Waqas, Muhammad, et al.
Publicado: (2017)

Serum endocan levels before and after surgery on low-grade gliomas
por: Tanriverdi, Taner, et al.
Publicado: (2017)

Genomic Insights into Diffuse Intrinsic Pontine Glioma
por: Lapin, Danielle H., et al.
Publicado: (2017)

LGG-60. Development and implementation of a complementary diagnostic tool to detect targetable pathways in pediatric glioma patients
por: Nobre, Liana, et al.
Publicado: (2022)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology
por: Zaccagna, Fulvio, et al.
Publicado: (2019)

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement
por: Belhawi, Sinan M. K., et al.
Publicado: (2011)

Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice
por: Thust, S. C., et al.
Publicado: (2018)

LGG-61. Cerebrospinal fluid as a source for liquid biopsy in pediatric gliomas
por: Nobre, Liana, et al.
Publicado: (2022)

Grading of carotid artery stenosis with multidetector-row CT angiography: visual estimation or caliper measurements?
por: Waaijer, Annet, et al.
Publicado: (2009)

Intensity standardization of MRI prior to radiomic feature extraction for artificial intelligence research in glioma—a systematic review
por: Fatania, Kavi, et al.
Publicado: (2022)

Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
por: Ceglie, Giulia, et al.
Publicado: (2020)

Review on neuroimaging in pediatric-type diffuse low-grade gliomas
por: Chen, Jing, et al.
Publicado: (2023)

Germline microsatellite genotypes differentiate children with medulloblastoma
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2020)

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
por: Desai, Ami V, et al.
Publicado: (2022)

The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma
por: Li, Xiaoyu, et al.
Publicado: (2022)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
por: Plotkin, Scott R, et al.
Publicado: (2023)

Brain volume perfusion CT performed with 128-detector row CT system in patients with cerebral gliomas: A feasibility study
por: Xyda, Argyro, et al.
Publicado: (2011)

Impact of the revised WHO classification of diffuse low-grade glioma on clinical decision making: A case report
por: van der Vlis, Tim A. M. Bouwens, et al.
Publicado: (2017)

Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature
por: Francaviglia, Natale, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4crh90752ut79rtrrha5vrfrlv